Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
– Shares of combined company to commence trading on Nasdaq Global Market under the symbol “LRMR” on May 29, 2020– […]
Regency Centers to Present at Nareit’s REITweek: 2020 Virtual Investor Conference
JACKSONVILLE, Fla., May 29, 2020 (GLOBE NEWSWIRE) — Regency Centers Corporation (“Regency” or the “Company”) (NASDAQ:REG) today announced that Lisa […]
Bio-Path Holdings Presents at 2020 American Society of Clinical Oncology Annual Meeting
HOUSTON, May 29, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense […]
Galera Therapeutics Announces Avasopasem Manganese Improved Markers of Chronic Kidney Disease in Patients Receiving Cisplatin
MALVERN, Penn., May 29, 2020 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing […]
21Vianet Announces Appointment of Executive Chairman for its Retail IDC Business Group
BEIJING, May 29, 2020 (GLOBE NEWSWIRE) — 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier- and […]
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program
– Data continue to show encouraging clinical activity alongside tolerable safety to deliver a potentially highly differentiated product profile –Conference […]
BridgeBio Pharma’s QED Therapeutics Presents Data on Infigratinib in Cholangiocarcinoma and Urothelial Carcinoma at the American Society of Clinical Oncology 2020 Virtual Scientific Program
SAN FRANCISCO, May 29, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) affiliate QED Therapeutics announced today that it […]
Myriad Presents New Data at ASCO Validating the Ability of riskScore® to Provide Personalized Breast Cancer Risk Information to Patients
SALT LAKE CITY, May 29, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]
Akari Therapeutics Reports First Quarter 2020 Financial Results and Highlights Recent Clinical Progress
Open pivotal study in pediatric hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) with orphan and fast track approvalPreparing for pivotal […]
TELA Bio to Present at the Jefferies Virtual Healthcare Conference
MALVERN, Pa., May 29, 2020 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company […]
